Southport Capital Management’s Zimmer Biomet ZBH Stock Holding History

Southport Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-451	Closed	-$58K	–	532
2018 Q3	$58K	Sell	451 -2,196	-83%	-$261K	0.02%	239
2018 Q2	$286K	Sell	2,647 -920	-26%	-$100K	0.13%	149
2018 Q1	$378K	Sell	3,567 -285	-7%	-$33.1K	0.17%	143
2017 Q4	$451K	Buy	+3,852	New	+$436K	0.17%	139
2016 Q3	–	Sell	-593	Closed	-$69K	–	473
2016 Q2	$69K	Buy	+593	New	+$67.1K	0.04%	264

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Southport Capital Management's ZBH Position: Q4 2018 in Review

Southport Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 451 shares — an estimated $58K sold.

Southport Capital Management first reported a position in ZBH in Q2 2016 and held it in 5 quarters. The position peaked at $451K in Q4 2017. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Southport Capital Management reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Southport Capital Management sold 451 Zimmer Biomet shares in Q4 2018, an estimated $58K.
Southport Capital Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 5 quarters.
Southport Capital Management's Zimmer Biomet position peaked at $451K in Q4 2017.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.